摘要
过去的五年见证了半经验量子力学(SQM)在虚拟药物设计方法中的复兴,很大程度上是由于所谓的强化SQM法精度的提高。这些方法利用添加的术语去处理分散(D)和氢键(H)结合以及色散校正的密度泛函理论(DFT-D)的精度。DFT-D反过来被证明能提供在非共价分子间的作用力中与精度相媲美的最先进的质量管理方法,它一般主导了虚拟药物设计中心的蛋白-配体相互作用。增强版SQM法因此提供了一个非常有前景的方法来改善目前虚拟药物设计领域的状态。
关键词: 生物分子相互作用;计算化学;分散作用;增强半经验质量管理法;计算机药物设计。
Current Medicinal Chemistry
Title:Prospects of Applying Enhanced Semi-Empirical QM Methods for 2101 Virtual Drug Design
Volume: 23 Issue: 20
Author(s): Nusret Duygu Yilmazer and Martin Korth
Affiliation:
关键词: 生物分子相互作用;计算化学;分散作用;增强半经验质量管理法;计算机药物设计。
摘要: The last five years have seen a renaissance of semiempirical quantum mechanical (SQM) methods in the field of virtual drug design, largely due to the increased accuracy of so-called enhanced SQM approaches. These methods make use of additional terms for treating dispersion (D) and hydrogen bond (H) interactions with an accuracy comparable to dispersion-corrected density functional theory (DFT-D). DFT-D in turn was shown to provide an accuracy comparable to the most sophisticated QM approaches when it comes to non-covalent intermolecular forces, which usually dominate the protein/ligand interactions that are central to virtual drug design. Enhanced SQM methods thus offer a very promising way to improve upon the current state of the art in the field of virtual drug design.
Export Options
About this article
Cite this article as:
Nusret Duygu Yilmazer and Martin Korth , Prospects of Applying Enhanced Semi-Empirical QM Methods for 2101 Virtual Drug Design, Current Medicinal Chemistry 2016; 23 (20) . https://dx.doi.org/10.2174/0929867323666160517120005
DOI https://dx.doi.org/10.2174/0929867323666160517120005 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Isoindole Derivatives: Propitious Anticancer Structural Motifs
Current Topics in Medicinal Chemistry Epigenetic Modulators as Treatment Alternative to Diverse Types of Cancer
Current Medicinal Chemistry Recent Advances in the Membrane Receptor Initiated Vitamin D Signaling of Calcium and Phosphate Transport Across Intestinal and Kidney Epithelia
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Natural Polymers Based Hydrogels for Cell Culture Applications
Current Medicinal Chemistry A Classification Method for Microarrays Based on Diversity
Current Bioinformatics Chromogranin A in Tumors: More Than a Marker for Diagnosis and Prognosis
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents Exploring the Management of Statin Intolerant Patients: 2016 and Beyond
Current Vascular Pharmacology Emergence of Ad-Mediated Combination Therapy Against Cancer: What to Expect?
Current Cancer Drug Targets Advances in peptidic and peptidomimetic-based approaches to inhibit STAT signaling in human diseases
Current Protein & Peptide Science Editorial (Thematic Issue: Structure-Function Based Drug Design for Cancer Therapeutics)
Current Pharmaceutical Biotechnology LFA-1 on Leukemic Cells as a Target for Therapy or Drug Delivery
Current Pharmaceutical Design Multiple Forms of Proteasomes and their Role in Tumor Fate
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Structure, DNA Binding and Cytotoxicity Studies of [Cu(D-glu)(phen)(H2O)]•NO3•2H2O
Letters in Drug Design & Discovery Madhuca indica Inhibits Breast Cancer Cell Proliferation by Modulating COX-2 Expression
Current Molecular Medicine From Natural Products to Small Molecule Ketone Histone Deacetylase Inhibitors: Development of New Class Specific Agents
Current Pharmaceutical Design Annexins Bend Wound Edges during Plasma Membrane Repair
Current Medicinal Chemistry The Potential Use of Hormone-Based Therapeutics for the Treatment of Alzheimers Disease
Current Alzheimer Research How to Advise Aspirin Use in Patients Who Need NSAIDs
Current Pharmaceutical Design Theranostic Radiopharmaceuticals Targeting Cancer-Associated Fibroblasts
Current Radiopharmaceuticals Regulation of Autophagy in Oxygen-Dependent Cellular Stress
Current Pharmaceutical Design